Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 33: 587-588, 1987;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mackness, M. I.
Right arrow Articles by Carlson, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mackness, M. I.
Right arrow Articles by Carlson, L. A.

Clinical Chemistry, Vol 33, 587-588, Copyright © 1987 by American Association for Clinical Chemistry

Low A-esterase activity in serum of patients with fish-eye disease

MI Mackness, CH Walker and LA Carlson

The activity of HDL-associated paraoxonase in the lipoprotein fraction of serum from two patients with fish-eye disease (FED) was only 11% of the mean value for control subjects. Similarly, concentrations of apolipoproteins A-I and A-II in the serum of FED subjects were only 10% of those in normal subjects. Thus the ratio of enzyme activity to A-I and A-II is virtually the same in these two groups of subjects. This suggests that paraoxonase activity of the lipoprotein fraction is associated with one or both of these apolipoproteins.


The following articles in journals at HighWire Press have cited this article:


Home page
 Nephrol Dial TransplantHome page
V. Charlton-Menys, L. Pisciotta, P. N. Durrington, R. Neary, C. D. Short, L. Calabresi, S. Calandra, and S. Bertolini
Molecular characterization of two patients with severe LCAT deficiency
Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2379 - 2382.
[Full Text] [PDF]

Home page
 J. Lipid Res.Home page
L. Gaidukov, M. Rosenblat, M. Aviram, and D. S. Tawfik
The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux
J. Lipid Res., November 1, 2006; 47(11): 2492 - 2502.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
P. N. Durrington, B. Mackness, and M. I. Mackness
Paraoxonase and Atherosclerosis
Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 473 - 480.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. C. Sorenson, C. L. Bisgaier, M. Aviram, C. Hsu, S. Billecke, and B. N. La Du
Human Serum Paraoxonase/Arylesterase's Retained Hydrophobic N-Terminal Leader Sequence Associates With HDLs by Binding Phospholipids : Apolipoprotein A-I Stabilizes Activity
Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2214 - 2225.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
I. Leviev, F. Negro, and R. W. James
Two Alleles of the Human Paraoxonase Gene Produce Different Amounts of mRNA : An Explanation for Differences in Serum Concentrations of Paraoxonase Associated With the (Leu-Met54) Polymorphism
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2935 - 2939.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
D. K. Sanghera, N. Saha, C. E. Aston, and M. I. Kamboh
Genetic Polymorphism of Paraoxonase and the Risk of Coronary Heart Disease
Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1067 - 1073.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. A. Hegele, J. H. Brunt, and P. W. Connelly
A Polymorphism of the Paraoxonase Gene Associated With Variation in Plasma Lipoproteins in a Genetic Isolate
Arterioscler Thromb Vasc Biol, January 1, 1995; 15(1): 89 - 95.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Association for Clinical Chemistry.